Recovered coronavirus patients who tested positive again weren't infectious, Korean CDC finds
The Korean Centers for Disease Control and Prevention released findings late Monday after studying 285 COVID-19 survivors who tested positive for the coronavirus again after presumably recovering the illness. The virus samples collected from the patients couldn't be grown in culture, suggesting that the patients had indeed recovered and were actually shedding non-infectious or dead virus particles, rather than suffering from a lingering infection, Bloomberg reports.
While there will likely be more work done in this area, it's encouraging news, and South Korean health authorities — who have received praise for setting a global standard during the pandemic — will no longer consider people infectious after they recover from their illness and won't require additional tests after patients are discharged from their isolation period. That means those patients won't have to test negative before returning to work or school.
Another positive sign from the findings is that almost all of the cases for which blood cases were taken had antibodies against the virus, which lends credence to the theory that people who were previously infected have built up some form of protection. Read more at Bloomberg.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How to invest in the artificial intelligence boomThe Explainer Artificial intelligence is the biggest trend in technology, but there are fears that companies are overvalued
-
The Week Unwrapped: Are British rappers the world’s best?Podcast Plus can the Maldives quit smoking? And can whales lead us to immortality?
-
The week’s best photosIn Pictures A leap through the leaves, a typhoon's aftermath, and more
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
